Analysis of the expression of cell cycle regulating genes in gastrointestinal tumors
胃肠道肿瘤细胞周期调控基因的表达分析
基本信息
- 批准号:07457273
- 负责人:
- 金额:$ 4.74万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The expression of cell cycle regurating genes, eg., positive regulators : G1 cyclins (cyclin D,E), cyclin dependent kinases (CDK2,4), negative regulators : CDK inhibitor (CDK4I/pI6), RB,in normal mucosa, hyperplasia, adenoma, carcinoma in adenoma and advanced carcinoma of colorectum was analyzed by immunohistochemistry and Western blottings. In normal mucosa, each protein was detected only in a few cells of bottom parts of the gland. In hyperplastic mucosa, the expression of cyclin D and E was detected in large number of cells of upper parts from the bottom of the gland. In adenomas, the overexpression of these proteins are frequently detected, eg., cyclin D : 55/66 (83%), cyclin E : 42/50 (84%). In carcinoma in adenoma, the overexpression of CDK2, p16 and RB,as well as cyclin D,E,was noted, eg., cyclin D : 8/8 (100%), cyclin E : 13/13 (100%), CDK2 : 10/12 (83%), p16 : 10/14 (71%), RB : 10/12 (83%). Finally, in advanced carcinomas, all the proteins were overexpressed, eg., cyclin D : 2 … More 6/45 (58%), cyclin E : 41/45 (91%), CDK2 : 34/45 (76%), CDK4 : 39/45 (87%), p16 : 59/60 (98%), RB : 34/45 (76%). The quantitative analysis by Western blottings further confirmed a few times higher expression of these proteins in colon carcinomas compared to normal mucosa. Also, the rate of hyperphosphorylated (inactivated) form of RB was shown to be 1.46 times higher compared to normal mucosa. The comparative analysis using immunohistochemistry on the adjacent sections revealed that the cancer cells overexpressing RB also overexpressed cyclin E/CDK2 and those overexpressing CDK4 also expressed p16. In summary, during the multistep colon carcinogenesis based on adenoma-carcinoma sequence, cyclin D and E are overexpressed from the stage of hyperplasia or adenoma, CDK2 and CDK4I/p16 are overexpressed from the stage of carcinoma in adenoma, and CDK4 is overexpressed at the stage of advanced carcinoma. Thus, it was suggested that the expression of cell cycle regulators such as G1 cyclins, CDKs and CDK inhibitors are deeply involved in colon carcinogenesis. And, the overexpression of cyclin E/CDK2 was thought to be involved in hyperphosphorylation of RB protein. Less
细胞周期调控基因的表达。免疫组化和Western blotting分析正常粘膜、增生、腺瘤、腺瘤中癌和晚期结直肠癌中的阳性调节因子:G1细胞周期蛋白(cyclin D、E)、细胞周期蛋白依赖激酶(CDK2、4),阴性调节因子:CDK抑制剂(CDK4I/pI6)、RB。在正常粘膜中,每种蛋白仅在腺体底部的少数细胞中检测到。在增生性粘膜中,从腺体底部开始的上部细胞中大量检测到cyclin D和E的表达。在腺瘤中,经常检测到这些蛋白的过表达。cyclin D: 55/66 (83%), cyclin E: 42/50(84%)。在腺瘤癌中,我们注意到CDK2、p16和RB以及细胞周期蛋白D、E的过表达,例如。, cyclin D: 8/8 (100%), cyclin E: 13/13 (100%), CDK2: 10/12 (83%), p16: 10/14 (71%), RB: 10/12(83%)。最后,在晚期癌症中,所有的蛋白质都过度表达,例如。cyclin D: 2…More 6/45 (58%), cyclin E: 41/45 (91%), CDK2: 34/45 (76%), CDK4: 39/45 (87%), p16: 59/60 (98%), RB: 34/45 (76%)Western blotting定量分析进一步证实,这些蛋白在结肠癌中的表达比正常粘膜高几倍。此外,与正常粘膜相比,RB过磷酸化(失活)形式的比率高出1.46倍。相邻切片免疫组化对比分析发现,过表达RB的癌细胞也过表达cyclin E/CDK2,过表达CDK4的癌细胞也过表达p16。综上所述,在基于腺瘤-癌序列的多阶段结肠癌发生过程中,cyclin D和E在增生或腺瘤阶段过表达,CDK2和CDK4I/p16在腺瘤癌阶段过表达,CDK4在晚期癌阶段过表达。因此,我们认为细胞周期调节因子如G1周期蛋白、CDKs和CDK抑制剂的表达深入参与结肠癌的发生。并且,cyclin E/CDK2的过表达被认为参与RB蛋白的过度磷酸化。少
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
門田卓士: "G1サイクリンおよびCDKの発現異常" 細胞. 29(7). 254-259 (1997)
Takashi Kadota:“G1 细胞周期蛋白和 CDK 的异常表达”细胞 29(7)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
門田卓士: "サイトカイン療法の試み" 外科治療. 72. 443-452 (1995)
Takashi Kadota:“细胞因子疗法的试验”手术治疗。72. 443-452 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
門田卓士: "OK-432+Fibrinogenの注入療法とその生物学的Rationale-特集:癌と凝固・線溶" Biotherapy. 10(8). 1075-1081 (1996)
Takashi Kadota:“OK-432+纤维蛋白原注射疗法及其生物学原理-专题:癌症和凝血/纤维蛋白溶解”生物疗法10(8)1075-1081(1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y,Yamamoto: "Analysis of cytotoxic activity of the CD4^+ Tlymphocytes generated by local immunotherapy" British Journal of Cancer. 73. 110-116 (1996)
Y,Yamamoto:“局部免疫疗法产生的 CD4^ T 淋巴细胞的细胞毒活性分析”英国癌症杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohue, M., Tomita, N., Monden, T., Miyoshi, Y., Ohnishi, T., Izawa, H., Kawabata, Y., Sasaki, M., Sekimoto, M., Nishisho, I., Shiozaki, H.and Monden, M.: "Mutations of the tranforming growth factor beta type II receptor gene and microsatellite instability
Ohue, M.、Tomita, N.、Monden, T.、Miyoshi, Y.、Ohnishi, T.、Izawa, H.、Kawabata, Y.、Sasaki, M.、Sekimoto, M.、Nishisho, I.、
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOMITA Naohiro其他文献
TOMITA Naohiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOMITA Naohiro', 18)}}的其他基金
Combination of splicing factor inhibitor and histone deacetylase inhibitor
剪接因子抑制剂和组蛋白脱乙酰酶抑制剂的组合
- 批准号:
23591975 - 财政年份:2011
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of DNA replication error and other genetic altherations in colorectal tumor.
结直肠肿瘤中 DNA 复制错误和其他遗传改变的分析。
- 批准号:
07671390 - 财政年份:1995
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of gene alterations in the premalignant lesion of colorectum
结直肠癌前病变基因改变分析
- 批准号:
05671063 - 财政年份:1993
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence
研究结直肠腺瘤-癌序列中的 Wnt 端粒反馈环路
- 批准号:
10232000 - 财政年份:2021
- 资助金额:
$ 4.74万 - 项目类别:
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence
研究结直肠腺瘤-癌序列中的 Wnt 端粒反馈环路
- 批准号:
10395445 - 财政年份:2021
- 资助金额:
$ 4.74万 - 项目类别:
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence
研究结直肠腺瘤-癌序列中的 Wnt 端粒反馈环路
- 批准号:
10570829 - 财政年份:2021
- 资助金额:
$ 4.74万 - 项目类别:
Distinct G protein-coupled receptors signaling pathway in the serrated neoplasia pathway and the conventional adenoma-carcinoma sequence of the colorectum
锯齿状肿瘤通路和结直肠常规腺瘤-癌序列中独特的G蛋白偶联受体信号通路
- 批准号:
15K19059 - 财政年份:2015
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Do any vascular change reflect the neoplastic transformation in the intestinal tract during the adenoma-carcinoma sequence?
在腺瘤-癌过程中,是否有任何血管变化反映了肠道的肿瘤转化?
- 批准号:
20890231 - 财政年份:2008
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Young Scientists (Start-up)